Page last updated: 2024-09-03

3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and coproporphyrin i

3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with coproporphyrin i in 2 studies

Compound Research Comparison

Studies
(3-carboxy-4-methyl-5-propyl-2-furanpropionic acid)
Trials
(3-carboxy-4-methyl-5-propyl-2-furanpropionic acid)
Recent Studies (post-2010)
(3-carboxy-4-methyl-5-propyl-2-furanpropionic acid)
Studies
(coproporphyrin i)
Trials
(coproporphyrin i)
Recent Studies (post-2010) (coproporphyrin i)
10063894844

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ando, T; Itoh, H; Mimata, H; Ohno, K; Ono, H; Sasamoto, Y; Shin, T; Suzuki, Y; Tanaka, R; Yoshijima, C1
Ishii, K; Itoh, H; Maeshima, K; Oda, A; Ohno, K; Ono, H; Ozaki, T; Shibata, H; Suzuki, Y; Tanaka, R; Tatsuta, R1

Other Studies

2 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and coproporphyrin i

ArticleYear
Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry.
    Journal of pharmaceutical and biomedical analysis, 2020, May-30, Volume: 184

    Topics: Adult; Aged; Chromatography, High Pressure Liquid; Coproporphyrins; Female; Furans; Humans; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Plasma; Propionates; Renal Insufficiency, Chronic; Solid Phase Extraction; Tandem Mass Spectrometry; Young Adult

2020
Factors Influencing Plasma Coproporphyrin-I Concentration as Biomarker of OATP1B Activity in Patients With Rheumatoid Arthritis.
    Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:4

    Topics: Aged; Arthritis, Rheumatoid; Biomarkers; Coproporphyrins; Female; Furans; Humans; Interleukin-6; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Pharmacogenomic Variants; Propionates; Tumor Necrosis Factor-alpha

2021